Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells
Michael Herbst, Hakan Köksal, Silvan Brunn, Dominik Zanetti, Ioana Domocos, Viola De Stefani, Marco Gatti, Francesca Vivalda, Paulo Pereira, Marc Nater, Virginia Cecconi, Alessandro A. Sartori, Maries F. van den Broek
This study shows that cancer-cell-derived cGAMP both enhances and limits CD8+ T cell anti-tumor activity through STING signaling.
Cell Reports · Apr 1, 2025Peer-reviewedImmunology